Kerry Crosby
Family · Wailuku, HINPI 1922675990
Payments from drug & device makers
Across 27 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$233
- Travere Therapeutics, Inc.$73
- Aurinia Pharma U.S., Inc.$61
- Calliditas Therapeutics US Inc.$43
- Nxstage Medical, Inc.$38
- Akebia Therapeutics Inc$30
- plus $92 from 4 others
What the payments were for
- Food & beverage$51791%
- Education$539%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 12 | $233 |
| Travere Therapeutics, Inc. | 3 | $73 |
| Aurinia Pharma U.S., Inc. | 3 | $61 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| Nxstage Medical, Inc. | 2 | $38 |
| Akebia Therapeutics Inc | 1 | $30 |
| Novartis | 1 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Bayer | 1 | $20 |
| Amgen | 1 | $19 |
How this compares
$570 in reported general payments places this provider in the 65th percentile of 466 family providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 37 | $131,378 |
| FarxigaDapagliflozin Propanediol | 32 | $43,286 |
| LokelmaSodium Zirconium Cyclosilicate | 12 | $18,343 |
| OzempicSemaglutide | 17 | $17,405 |
| Sevelamer Carbonate | 62 | $14,804 |
| JardianceEmpagliflozin | 12 | $11,286 |
| Torsemide | 16 | $875 |
| Nifedipine ErNifedipine | 26 | $872 |
| Losartan Potassium | 66 | $777 |
| Metoprolol Succinate | 35 | $747 |
| Atorvastatin Calcium | 43 | $625 |
| Amlodipine Besylate | 36 | $384 |
| Allopurinol | 35 | $368 |
| Carvedilol | 16 | $314 |
| Lisinopril | 31 | $306 |
Paid to pharmacies, not to this prescriber.
Other family in Wailuku
- Bryan ChinWailuku$3K
- Joey SesonHonolulu$48K
- Kanna DokgoHonolulu$26K
- John MosesHonolulu$24K
- Cecilia GreenWaipahu$21K
- Sherry Sutherland ChoyKahuku$21K
- Kristina HalloranAiea$12K
- Natalie KitamuraPearl City$11K
- Leif MarzHonolulu$11K
- Elizabeth CabreraWaianae$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.